ApoVax is a biotechnology company developing immunotherapies that regulate the immune system to fight disease.
Industries BiotechnologyMedicalPharmaceuticalHeadquarters Regions Southern US Founded Date 2001 Founders Haval Shirwan Operating Status Active Last Funding Type Debt Financing Also Known As ApoVax Inc.
Company Type For Profit
Contact Email dlynch@apovax.com Phone Number 5025691021
ApoVax, Inc., a biotechnology company, develops immunotherapies for regulating the immune system to fight against diseases. Its products include ApoVax104, a recombinant protein vaccine that combines with antigens, tumors, and infectious disease markers and stimulates an immune response to create a disease-specific vaccine or therapeutic; and
ProtEx, a technology that enables recombinant immunoregulatory proteins to be placed on the surface of cells, tissues, organs, and synthetic surfaces to modulate the immune system. The company’s products also include ApoVax104-HPV, a therapeutic vaccine for cervical cancer and human papillomavirus infection in women. In addition, its research programs c...